Diabetes drug showdown: which works better for indian patients?
Disease control
Not yet recruiting
This study compares two common diabetes medications, dapagliflozin and empagliflozin, to see which works better for Indian patients with type 2 diabetes and higher body weight. Researchers will measure blood sugar control, weight changes, organ function, and treatment costs over …
Phase: PHASE4 • Sponsor: Bhavya Bhavya, MD • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC